相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。delta-Secretase-cleaved Tau stimulates A beta production via upregulating STAT1-BACE1 signaling in Alzheimer's disease
Zhentao Zhang et al.
MOLECULAR PSYCHIATRY (2021)
Early Intervention in Alzheimer's Disease: How Early is Early Enough?
Dong-Yu Fan et al.
NEUROSCIENCE BULLETIN (2020)
Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model
Lynn van Olst et al.
NEUROBIOLOGY OF AGING (2020)
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Zhentao Zhang et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease
Seong Su Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Blockade of the forward Na+/Ca2+ exchanger suppresses the growth of glioblastoma cells through Ca2+-mediated cell death
Hui-Jie Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies
Jie Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease
Zhi-Hao Wang et al.
NATURE COMMUNICATIONS (2018)
Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
S. Gauthier et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Alzheimer's disease: The right drug, the right time Lessons from failed clinical trials can improve the development of Alzheimer's disease-modifying therapies
Todd E. Golde et al.
SCIENCE (2018)
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Roy M. Anderson et al.
LANCET (2017)
Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice
Mingke Song et al.
NEUROBIOLOGY OF DISEASE (2017)
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2017)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases
Zhentao Zhang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Microglial immunophenotype in dementia with Alzheimer's pathology
Thais Minett et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai
Chun-Xia Ban et al.
TRANSLATIONAL NEURODEGENERATION (2016)
Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)
D. Porquet et al.
AGE (2015)
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2015)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease
John E. Morley et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Prevention strategies for Alzheimer's disease
Serge Gauthier et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting A beta and tau
Yang Hong-Qi et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Animal models in the drug discovery pipeline for Alzheimer's disease
Debby Van Dam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Senescence-accelerated Mouse (SAM): A Higher Oxidative Stress and Age-dependent Degenerative Diseases Model
Yoichi Chiba et al.
NEUROCHEMICAL RESEARCH (2009)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)